share_log

首药控股(688197.SH)业绩快报:2023年净亏损1.84亿元

First Pharmaceutical Holdings (688197.SH) Performance Report: Net loss of 184 million yuan in 2023

Gelonghui Finance ·  Jan 30 06:24

Gelonghui, January 30丨First Pharmaceutical Holdings (688197.SH) announced its 2023 annual results report. During the reporting period, the company achieved total operating income of 5,2292 million yuan, an increase of 186.19% year on year; R&D expenses of 201.206 million yuan, up 0.89% year on year; net profit attributable to owners of the parent company - 18.38443 million yuan, a year-on-year increase of 10.275 million yuan; net profit attributable to owners of the parent company after deducting non-recurring profit and loss of 197.22.5 million yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment